Prostate cancer: Brachytherapy monotherapy is efficacious
Sign Up to like & getrecommendations! Published in 2017 at "Nature Reviews Urology"
DOI: 10.1038/nrurol.2017.195
Abstract: A randomized, open-label phase III trial of custirsen in 635 men with metastatic castration-resistant prostate cancer that had progressed after docetaxel showed no survival benefit for the addition of custirsen to cabazitaxel plus prednisone treatment.… read more here.
Keywords: brachytherapy monotherapy; prostate cancer; cancer brachytherapy; monotherapy efficacious ... See more keywords